<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0188-9532</journal-id>
<journal-title><![CDATA[Revista mexicana de ingeniería biomédica]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. ing. bioméd]]></abbrev-journal-title>
<issn>0188-9532</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Ingeniería Biomédica]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0188-95322019000200101</article-id>
<article-id pub-id-type="doi">10.17488/rmib.40.2.1</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Medicina Regenerativa para Úlceras Crónicas: Aplicación Cutánea de Células Troncales Mesenquimales de Gelatina de Wharton]]></article-title>
<article-title xml:lang="en"><![CDATA[Regenerative Medicine for Chronic Ulcers: Cutaneous Application of Mesenchymal Stem Cells of Wharton&#8217;s Jelly]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Parra-Barrera]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mejía-Barradas]]></surname>
<given-names><![CDATA[C. M.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Calzada-Mendoza]]></surname>
<given-names><![CDATA[C. C.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mera-Jiménez]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez-Corrales]]></surname>
<given-names><![CDATA[A. L.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gutiérrez-Iglesias]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Politécnico Nacional Escuela Superior de Medicina ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2019</year>
</pub-date>
<volume>40</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0188-95322019000200101&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0188-95322019000200101&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0188-95322019000200101&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen El empleo de células mesenquimales ha emergido como una parte importante en la medicina regenerativa con efectos positivos en la recuperación de tejidos dañados o perdidos. Las úlceras crónicas incluyen lesiones cutáneas que afectan a una gran parte de la población con diabetes mellitus, (por ejemplo 9.14% desarrollan lesiones por pie diabético según ENSANUT 2016) y representan gastos económicos considerables, debido a la pobre calidad de vida que llevan los pacientes. El tratamiento convencional que se lleva a cabo en estos casos es a largo plazo, y los efectos benéficos generados que se presentan son limitados, ya que las lesiones reinciden por no contar con un tratamiento específico y regenerativo, solo paliativo. Es por ello que en este trabajo se obtuvieron y emplearon células troncales mesenquimales derivadas de gelatina de Wharton (CTM-GW) bajo los criterios propuestos por la Sociedad Internacional de la Terapia Celular. El tratamiento fue aplicado en dos pacientes con úlceras crónicas flebostáticas de diferentes condiciones médicas y se monitoreo a corto plazo, por lo que fue un estudio limitado. Los resultados mostraron que las CTM-GW indujeron la reconstrucción cutánea mediante formación de tejido de granulación, además de disminuir el proceso inflamatorio crónico en la zona de daño, lo que favoreció el índice de cierre de la herida. Por lo anterior, se propone la utilización de CTM-GW en úlceras flebostáticas crónicas como tratamiento en la regeneración de la estructura tisular con resultados a corto plazo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Use of mesenchymal cells has emerged as an important part in regenerative medicine with positive effects in the recovery of damaged or lost tissues. Chronic ulcers include skin lesions that affect a large part of the population with diabetes mellitus, (for example, 9.14 develop diabetic foot according to ENSANUT 2016) and represent considerable economic expenses, due to poor quality of life in patients. The conventional treatment that is carried out in these cases is long term, and the generated beneficial effects that are presented are limited, since the injuries recur due to not having a specific and regenerative treatment, only palliative. That is why in this work they were obtained and used mesenchymal stem cells derived from Wharton's jelly (MSC-WJ) under the criteria proposed by the International Society for Cell Therapy. The treatment was applied in two patients with chronic ulcers phlebostatic of different medical conditions and short-term monitoring, so it was a limited study. The results showed that MSC-WJ induced skin reconstruction by tissue formation granulation, in addition to decreasing the chronic inflammatory process in the area of damage, which favored the index of wound healing. Therefore, the use of MSC-WJ in chronic phlebostatic ulcers is proposed as a treatment in the regeneration of the tissue structure with short-term results.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Medicina Regenerativa]]></kwd>
<kwd lng="es"><![CDATA[Células Troncales Mesenquimales de Gelatina de Wharton]]></kwd>
<kwd lng="es"><![CDATA[Úlceras crónicas]]></kwd>
<kwd lng="en"><![CDATA[Regenerative Medicine]]></kwd>
<kwd lng="en"><![CDATA[Mesenchymal Stem Cells]]></kwd>
<kwd lng="en"><![CDATA[Chronic Ulcers]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>[1]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Adderley]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Venous leg ulcers]]></article-title>
<source><![CDATA[BMJ Clin Evid]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>[2]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global burden of obesity in 2005 and projections to 2030]]></article-title>
<source><![CDATA[Int J Obes]]></source>
<year>2008</year>
<volume>32</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1431-7</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>[3]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aberdam]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Derivation of keratinocyte progenitor cells and skin formation from embryonic stem cells]]></article-title>
<source><![CDATA[Int J Dev Biol.]]></source>
<year>2004</year>
<volume>48</volume>
<numero>2-3</numero>
<issue>2-3</issue>
<page-range>203-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>[4]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agale]]></surname>
<given-names><![CDATA[SV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic Leg Ulcers: Epidemiology, Aetiopathogenesis, and Management]]></article-title>
<source><![CDATA[Ulcers]]></source>
<year>2013</year>
<volume>2013</volume>
<page-range>9</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>[5]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alzahrani]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Healing of chronic diabetic foot ulcers with a skin substitute: Patient selection is the key to success]]></article-title>
<source><![CDATA[Open Journal of Regenerative Medicine]]></source>
<year>2013</year>
<volume>2</volume>
<page-range>15-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>[6]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Antunez]]></surname>
<given-names><![CDATA[G.F.T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento combinado para úlcera venosa crónica: compresión, escleroterapia de perforantes guiada por ultrasonido e injerto de piel]]></article-title>
<source><![CDATA[Revista Mexicana de Angiología]]></source>
<year>2008</year>
<volume>36</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>[7]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Atala]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Engineering complex tissues]]></article-title>
<source><![CDATA[Sci Transl Med]]></source>
<year>2012</year>
<volume>4</volume>
<numero>160</numero>
<issue>160</issue>
<page-range>160rv12</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>[8]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marfia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds]]></article-title>
<source><![CDATA[Organogenesis]]></source>
<year>2015</year>
<volume>11</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>183-206</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>[9]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acevedo-Olvera]]></surname>
<given-names><![CDATA[L.F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of dehydroepiandrosterone on expression of BMP2, SPARC and RUNX2 in human bone marrow mesenchymal stem cells]]></article-title>
<source><![CDATA[Revista Mexicana de Ingeniería Química]]></source>
<year>2016</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>[10]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parra-Barrera]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparación entre Células Troncales Mesenquimales obtenidas de Médula Ósea, Tejido Adiposo y Gelatina de Wharton en base a los Criterios de la ISCT]]></article-title>
<source><![CDATA[Revista Mexicana de Ingeniería Biomédica]]></source>
<year>2017</year>
<volume>38</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>280-7</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>[11]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Erices]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Conget]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Minguell]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal progenitor cells in human umbilical cord blood]]></article-title>
<source><![CDATA[Br J Haematol]]></source>
<year>2000</year>
<volume>109</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>235-42</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>[12]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roufosse]]></surname>
<given-names><![CDATA[C.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Circulating mesenchymal stem cells]]></article-title>
<source><![CDATA[Int J Biochem Cell Biol]]></source>
<year>2014</year>
<volume>36</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>585-97</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>[13]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meng]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endometrial regenerative cells: a novel stem cell population]]></article-title>
<source><![CDATA[J Transl Med]]></source>
<year>2007</year>
<volume>15</volume>
<page-range>57</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>[14]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gronthos]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo]]></article-title>
<source><![CDATA[Proc Natl Acad Sci US]]></source>
<year>2000</year>
<volume>97</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>13625-30</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>[15]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sessarego]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application]]></article-title>
<source><![CDATA[Haematologica]]></source>
<year>2008</year>
<volume>93</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>339-46</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>[16]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[X.L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway]]></article-title>
<source><![CDATA[Breast Cancer Res Treat]]></source>
<year>2012</year>
<volume>132</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>153-64</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>[17]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aktas]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Good manufacturing practice-grade production of unrestricted somatic stem cell from fresh cord blood]]></article-title>
<source><![CDATA[Cytotherapy]]></source>
<year>2010</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>338-48</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>[18]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manochantr]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord]]></article-title>
<source><![CDATA[Intern Med J]]></source>
<year>2013</year>
<volume>43</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>430-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>[19]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Semont]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal stem cell therapy stimulates endogenous host progenitor cells to improve colonic epithelial regeneration]]></article-title>
<source><![CDATA[PLoS ONE]]></source>
<year>2013</year>
<volume>8</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B20">
<label>[20]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Augustin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vanscheidt]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic venous leg ulcers: the future of cell-based therapies]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2012</year>
<volume>380</volume>
<numero>9846</numero>
<issue>9846</issue>
<page-range>953-5</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>[21]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zollino]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autologous adipose-derived stem cells: Basic science, technique, and rationale for application in ulcer and wound healing]]></article-title>
<source><![CDATA[Phlebology]]></source>
<year>2017</year>
<volume>32</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>160-71</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>[22]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis]]></article-title>
<source><![CDATA[Exp Ther Med]]></source>
<year>2016</year>
<volume>12</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>2983-9</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>[23]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zeng]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case report]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>2017</year>
<volume>96</volume>
<numero>51</numero>
<issue>51</issue>
<publisher-loc><![CDATA[Baltimore ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B24">
<label>[24]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Badiavas]]></surname>
<given-names><![CDATA[E.V.]]></given-names>
</name>
<name>
<surname><![CDATA[Falanga]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of chronic wounds with bone marrow-derived cells]]></article-title>
<source><![CDATA[Arch Dermatol]]></source>
<year>2003</year>
<volume>139</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>510-6</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>[25]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Savoji]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Skin Tissue Substitutes and Biomaterial Risk Assessment and Testing]]></article-title>
<source><![CDATA[Front Bioeng Biotechnol]]></source>
<year>2018</year>
<volume>6</volume>
<page-range>86</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>[26]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carriel]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ex Vivo and In Vivo Stem Cells-Based Tissue Engineering Strategies for Their Use in Regenerative Medicine]]></article-title>
<source><![CDATA[Stem Cells Int]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B27">
<label>[27]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dominici]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement]]></article-title>
<source><![CDATA[Cytotherapy]]></source>
<year>2006</year>
<volume>8</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>315-7</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>[28]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[SV]]></given-names>
</name>
<name>
<surname><![CDATA[Chakravarthy]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of a bovine 100% native collagen for the treatment of chronic wounds: a case series]]></article-title>
<source><![CDATA[J Wound Ostomy Continence Nurs]]></source>
<year>2015</year>
<volume>42</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>226-34</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>[29]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficient differentiation of vascular endothelial cells from dermal-derived mesenchymal stem cells induced by endothelial cell lines conditioned medium]]></article-title>
<source><![CDATA[Acta Histochem]]></source>
<year>2018</year>
<volume>21</volume>
</nlm-citation>
</ref>
<ref id="B30">
<label>[30]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez-Hernández]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento de úlceras venosas en las extremidades inferiores con autoinjertos en sacabocado más compresión contra compresión elástica]]></article-title>
<source><![CDATA[Dermatol Rev Mex]]></source>
<year>2014</year>
<volume>58</volume>
</nlm-citation>
</ref>
<ref id="B31">
<label>[31]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ganary]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The emerging use of bone marrow-derived mesenchymal stem cells in the treatment of human chronic wounds]]></article-title>
<source><![CDATA[Expert Opin. Emerging Drugs]]></source>
<year>2013</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1-15</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>[32]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benítez-Arvízu]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Células troncales mesenquimales autólogas e injerto cutáneo autólogo para tratamiento de una úlcera crónica secundaria a diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Cirugía y Cirujanos]]></source>
<year>2015</year>
<volume>83</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>532-6</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>[33]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amato]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of adult tissue-derived stem cells in chronic leg ulcers: a systematic review focused on tissue regeneration medicine]]></article-title>
<source><![CDATA[Int Wound J]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B34">
<label>[34]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marfia]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal Stem Cells: Potential For Therapy and Treatment Of Chronic Non-Healing Skin Wounds]]></article-title>
<source><![CDATA[Organogenesis]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B35">
<label>[35]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gadelkarima]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adipose-derived stem cells: Effectiveness and advances in delivery in diabetic wound healing]]></article-title>
<source><![CDATA[Biomedicine &amp; Pharmacotherapy]]></source>
<year>2018</year>
<volume>107</volume>
<page-range>625-33</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>[36]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Francesco]]></surname>
<given-names><![CDATA[Francesco De]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Regenerative Approach with Dermal Micrografts in the Treatment of Chronic Ulcers]]></article-title>
<source><![CDATA[Stem Cell Rev and Rep]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B37">
<label>[37]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nuschke]]></surname>
<given-names><![CDATA[Austin]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Activity of mesenchymal stem cells in therapies for chronic skin wound healing]]></article-title>
<source><![CDATA[Organogenesis]]></source>
<year>2014</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-37</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>[38]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Etulain]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelets in wound healing and regenerative medicine]]></article-title>
<source><![CDATA[Platelets]]></source>
<year>2018</year>
<volume>29</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>556-68</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>[39]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abou-Elela]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of oxidized cellulose hemostats (Surgicel) to support parenchymal closure and achieve hemostasis following partial nephrectomy]]></article-title>
<source><![CDATA[Surg Technol Int]]></source>
<year>2009</year>
<volume>18</volume>
<page-range>75-9</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>[40]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal stem cell-laden antiinflammatory hydrogel enhances diabetic wound healing]]></article-title>
<source><![CDATA[Scientific Reports]]></source>
<year>2015</year>
<volume>5</volume>
<page-range>18104</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>[41]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation]]></article-title>
<source><![CDATA[Int J Mol Med]]></source>
<year>2014</year>
<volume>34</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>695-704</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>[42]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caplan]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal stem cells]]></article-title>
<source><![CDATA[J Orthop Res]]></source>
<year>1991</year>
<volume>9</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>641-50</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>[43]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sasaki]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type]]></article-title>
<source><![CDATA[J Immunol]]></source>
<year>2008</year>
<volume>180</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>2581-7</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>[44]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yeh]]></surname>
<given-names><![CDATA[E.T.H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transdifferentiation of human peripheral blood CD34(+)-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2003</year>
<volume>108</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>2070-3</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>[45]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yianni]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Sharpe]]></surname>
<given-names><![CDATA[PT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Molecular programming of perivascular stem cell precursors]]></article-title>
<source><![CDATA[Stem Cells]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B46">
<label>[46]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of Deltex-1 on proliferation and differentiation of bone marrow mesenchymal stem cells into smooth muscle cells]]></article-title>
<source><![CDATA[Eur Rev Med Pharmacol Sci]]></source>
<year>2018</year>
<volume>22</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>3627-34</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>[47]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Differentiation of Human Amniotic Mesenchymal Stem Cells into Human Anterior Cruciate Ligament Fibroblast Cells by In Vitro Coculture]]></article-title>
<source><![CDATA[Biomed Res Int]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B48">
<label>[48]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soundararajan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kannan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fibroblasts and mesenchymal stem cells: Two sides of the same coin?]]></article-title>
<source><![CDATA[J Cell Physiol]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B49">
<label>[49]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chowdhury]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts]]></article-title>
<source><![CDATA[Oncotarget]]></source>
<year>2015</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>715-31</page-range></nlm-citation>
</ref>
<ref id="B50">
<label>[50]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Linard]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autologous Bone Marrow Mesenchymal Stem Cells Improve the Quality and Stability of Vascularized Flap Surgery of Irradiated Skin in Pigs]]></article-title>
<source><![CDATA[Stem Cells Transl Med]]></source>
<year>2018</year>
<volume>7</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>569-82</page-range></nlm-citation>
</ref>
<ref id="B51">
<label>[51]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lecarpentier]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human Bone Marrow Contains Mesenchymal Stromal Stem Cells That Differentiate In Vitro into Contractile Myofibroblasts Controlling T Lymphocyte Proliferation]]></article-title>
<source><![CDATA[Stem Cells Int]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B52">
<label>[52]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steffens]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of a biomaterial associated with mesenchymal stem cells and keratinocytes for use as a skin substitute]]></article-title>
<source><![CDATA[Regen Med]]></source>
<year>2015</year>
<volume>10</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>975-87</page-range></nlm-citation>
</ref>
<ref id="B53">
<label>[53]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seidelmann]]></surname>
<given-names><![CDATA[SB.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and pathologies of the arterial wall]]></article-title>
<source><![CDATA[Cell Mol Life Sci]]></source>
<year>2014</year>
<volume>71</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1977-99</page-range></nlm-citation>
</ref>
<ref id="B54">
<label>[54]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Raffetto]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathophysiology of wound healing and alterations in venous leg ulcers-review]]></article-title>
<source><![CDATA[Phlebology]]></source>
<year>2016</year>
<volume>31</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>56-62</page-range></nlm-citation>
</ref>
<ref id="B55">
<label>[55]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blaise]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Non-healing ischaemic digital ulcer in a systemic sclerosis patient: a challenging clinical case]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Roustit]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Forli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Imbert]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Cracowski]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<source><![CDATA[Int Wound J]]></source>
<year>2017</year>
<volume>14</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>978-81</page-range></nlm-citation>
</ref>
<ref id="B56">
<label>[56]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fiordaliso]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prospective study on microangiopathy in type 2 diabetic foot ulcer]]></article-title>
<source><![CDATA[Diabetologia]]></source>
<year>2016</year>
<volume>59</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1542-8</page-range></nlm-citation>
</ref>
<ref id="B57">
<label>[57]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model]]></article-title>
<source><![CDATA[Exp Mol Med]]></source>
<year>2018</year>
<volume>50</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>29</page-range></nlm-citation>
</ref>
<ref id="B58">
<label>[58]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Payushina]]></surname>
<given-names><![CDATA[OV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of Mesenchymal Stromal Cells and Conditioned Media on Healing of Skin Wound]]></article-title>
<source><![CDATA[Bull Exp Biol Med]]></source>
<year>2018</year>
<volume>165</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>572-5</page-range></nlm-citation>
</ref>
<ref id="B59">
<label>[59]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Navone]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Decellularized silk fibroin scaffold primed with adipose mesenchymal stromal cells improves wound healing in diabetic mice]]></article-title>
<source><![CDATA[Stem Cell Research &amp; Therapy]]></source>
<year>2014</year>
<volume>5</volume>
<page-range>7</page-range></nlm-citation>
</ref>
<ref id="B60">
<label>[60]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mineda Kazohide]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Therapeutic Potential of Human Adipose-Derived Stem/Stromal Cell Microspheroids Prepared by Three-Dimensional Culture in Non-Cross-Linked Hyaluronic Acid Gel]]></article-title>
<source><![CDATA[Stem Cells Traslational Medicine]]></source>
<year>2015</year>
<volume>4</volume>
<page-range>1511-22</page-range></nlm-citation>
</ref>
<ref id="B61">
<label>[61]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety and efficacy of intramuscular human placenta-derived mesenchymal stromal-like cells (cenplacel [PDA-002]) in patients who have a diabetic foot ulcer with peripheral arterial disease]]></article-title>
<source><![CDATA[Int Wound J]]></source>
<year>2017</year>
<volume>14</volume>
<page-range>823-9</page-range></nlm-citation>
</ref>
<ref id="B62">
<label>[62]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ribeiro]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cell Therapy with Human MSCs Isolated from the Umbilical Cord Wharton Jelly Associated to a PVA Membrane in the Treatment of Chronic Skin Wounds]]></article-title>
<source><![CDATA[Int. J. Med. Sci.]]></source>
<year>2014</year>
<volume>11</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>979-87</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
